Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Inovio and MedImmune establish cancer vaccine collaboration

Aug. 11, 2015

MabVax and Rockefeller University enter into research collaboration agreement

Aug. 11, 2015

The FDA grants orphan drug designation to daratumumab for follicular lymphoma

Aug. 10, 2015

FDA approves IND application for Valor's IGN-002

Aug. 7, 2015

Advaxis receives prostate cancer charity grants to develop ADXS-PSA

Aug. 7, 2015

MedImmune and Mirati to conduct trial combining durvalumab and mocetinostat

Aug. 5, 2015

Anti-GD2 antibody enters phase II trial in osteosarcoma

Aug. 3, 2015

Perjeta regimen approved in E.U. for use before surgery in early-stage breast cancer

Aug. 3, 2015

arGEN-X and University of Bern to develop ARGX-110-based combination therapies

Aug. 3, 2015

Scancell and ImmunID to use ImmunTraCkeR to predict response to SCIB-1

July 31, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...